dm+d

346670008

Articles

RMOC Recommendation: Standardising strengths of high risk, unlicensed oral liquids formulations for anti-TB medicines

9 April 2018At the meeting on 26th October 2017 the Regional Medicines Optimisation Committee (North) endorsed the approach put forward by the NHS Pharmaceutical Quality Assurance Committee…
Search Articles

Medicine Compliance Aid Stability

RifinahSanofi

Sanofi
Rifinah
Tablets 150mg/100mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from light and moisture
31 July 2015